A
AGMB//CIK 0002020932
Agomab Therapeutics NV
Market Data
$12.04+$1.94 (+19.21%)
AGMB · Last trade
Prev Close
$10.10
Range (29d)
$10.98 – $17.82
Recent Filings
- 6-K60.8 KBAgomab Therapeutics NVJun 23, 4:13 PM ET·0001104659-26-076819
- 6-K37.3 KBAgomab Therapeutics NVMay 27, 7:12 AM ET·0001104659-26-066590
- 6-K2.9 MBAgomab Therapeutics NVApr 24, 4:22 PM ET·0001104659-26-048615
- 6-K130.5 KBAgomab Therapeutics NVMar 5, 4:05 PM ET·0001104659-26-024095
- 6-K177.9 KBAgomab Therapeutics NVFeb 9, 4:18 PM ET·0001104659-26-012080
Insiders
10- Bond Colin MichaelDirector
- Borderias Andrea SaezChief Development Officer
- Epstein David RDirector
- Hammer OhadDirector
- Jahreis Angelika MarthaDirector
- Kemula Pierre Thadee VictorChief Financial Officer
- Knotnerus Tim JasperDirector, Chief Executive Officer
- Lefever EllenGeneral Counsel
- van der Horst Paul HenrykChief Business Officer
- Verduyn-van Weegen Felice IsabelDirector
Tickers
Addresses
business
POSTHOFLEI 1/6
ANTWERPEN, 2600
mailing
POSTHOFLEI 1/6
ANTWERPEN, 2600